<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00780585</url>
  </required_header>
  <id_info>
    <org_study_id>P05719</org_study_id>
    <secondary_id>2007-001611-32;</secondary_id>
    <secondary_id>153006</secondary_id>
    <nct_id>NCT00780585</nct_id>
  </id_info>
  <brief_title>A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)</brief_title>
  <official_title>A Multi-center Cardiac Safety Study of Subjects Who Participated in Organon Sponsored Phase 1 and Phase 2 Completed and Discontinued Trials With Org 24448</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a safety study evaluating the subjects who participated in previous Organon trials of
      the drug Org 24448. Patients will undergo a Screening visit, 1 or 2 Evaluation visits, and a
      possible Follow-Up period. During the visits, study tests, including echocardiograms, will be
      performed to summarize cardiac functioning.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects who participated in previous Org 24448 trials and who do not meet any of the
      exclusion criteria are eligible.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall cardiac function by cardiologist evaluation including echocardiogram.</measure>
    <time_frame>During the Evaluation Period (Visit 1 or 2 and 3 if applicable).</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">95</enrollment>
  <condition>Psychosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Subjects who participated in previous Org 24448 trials</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SCH 900460</intervention_name>
    <description>Subjects who participated in previous trials of Org 24448 (SCH 900460)</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Org 24448</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected from subjects who participated in previous Org 24448 trials
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subjects must:

          -  be verified by the investigator to have participated in a previous Organon sponsored
             Org 24448 trial.

          -  sign an affirmative informed consent before evaluations are conducted;

        Exclusion Criteria:

        Subjects must not have:

          -  a concurrent acute condition that could interfere with the conduct or interpretation
             of the evaluations (e.g. acute psychosis; respiratory illness; current experimental
             medications). If possible, evaluation of such subjects is deferred until resolution of
             such conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2008</study_first_submitted>
  <study_first_submitted_qc>October 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2008</study_first_posted>
  <last_update_submitted>December 18, 2014</last_update_submitted>
  <last_update_submitted_qc>December 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

